Back to Search
DAVID BAYLINK, M.D.
M.D.
Internal Medicine Physician
NPI: 1518983113Individual
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
G46488(CA)
Research & Publications (20)
Mapping of the chromosome 17 BMD QTL in the F(2) male mice of MRL/MpJ x SJL/J.
PMID 18330711·Genetica·2009
7-preclinical
Quantitative trait loci, genes, and polymorphisms that regulate bone mineral density in mouse.
PMID 19150398·Genomics·2009
6-review
Retroviral-based gene therapy with cyclooxygenase-2 promotes the union of bony callus tissues and accelerates fracture healing in the rat.
PMID 18088065·J Gene Med·2008
7-preclinical
A chemical mutagenesis screen to identify modifier genes that interact with growth hormone and TGF-beta signaling pathways.
PMID 18063435·Bone·2008
7-preclinical
Novel loci regulating bone anabolic response to loading: expression QTL analysis in C57BL/6JXC3H/HeJ mice cross.
PMID 17543594·Bone·2007
7-preclinical
Sca-1(+) hematopoietic cell-based gene therapy with a modified FGF-2 increased endosteal/trabecular bone formation in mice.
PMID 17637718·Mol Ther·2007
7-preclinical
Mapping genetic loci that regulate lipid levels in a NZB/B1NJxRF/J intercross and a combined intercross involving NZB/B1NJ, RF/J, MRL/MpJ, and SJL/J mouse strains.
PMID 17496333·J Lipid Res·2007
7-preclinical
Conditional deletion of insulin-like growth factor-I in collagen type 1alpha2-expressing cells results in postnatal lethality and a dramatic reduction in bone accretion.
PMID 17717052·Endocrinology·2007
7-preclinical
Nuclear factor-E2-related factor-1 mediates ascorbic acid induction of osterix expression via interaction with antioxidant-responsive element in bone cells.
PMID 17510056·J Biol Chem·2007
7-preclinical
Identification of mouse Duffy antigen receptor for chemokines (Darc) as a BMD QTL gene.
PMID 17416748·Genome Res·2007
7-preclinical
An improved mouse Sca-1+ cell-based bone marrow transplantation model for use in gene- and cell-based therapeutic studies.
PMID 17095856·Acta Haematol·2007
7-preclinical
The selective cyclooxygenase-2 inhibitor celecoxib reduces bone resorption, but not bone formation, in ovariectomized mice in vivo.
PMID 17347553·Tohoku J Exp Med·2007
4-observational
Modifications of the fibroblast growth factor-2 gene led to a marked enhancement in secretion and stability of the recombinant fibroblast growth factor-2 protein.
PMID 17243099·J Cell Biochem·2007
7-preclinical
Detecting novel bone density and bone size quantitative trait loci using a cross of MRL/MpJ and CAST/EiJ inbred mice.
PMID 17308992·Calcif Tissue Int·2007
7-preclinical
Genetic regulation of femoral bone mineral density: complexity of sex effect in chromosome 1 revealed by congenic sublines of mice.
PMID 17618849·Bone·2007
4-observational
A transmembrane osteoclastic protein-tyrosine phosphatase regulates osteoclast activity in part by promoting osteoclast survival through c-Src-dependent activation of NFkappaB and JNK2.
PMID 17400176·Arch Biochem Biophys·2007
7-preclinical
Disruption of insulin-like growth factor-I expression in type IIalphaI collagen-expressing cells reduces bone length and width in mice.
PMID 17519362·Physiol Genomics·2007
7-preclinical
Pregnancy-associated plasma protein-A increases osteoblast proliferation in vitro and bone formation in vivo.
PMID 16946002·Endocrinology·2006
7-preclinical
A platform of high-efficiency nonviral gene transfer in mouse osteoblast cells in vitro.
PMID 16943568·Mol Biotechnol·2006
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 11370 ANDERSON ST, STE 3150
LOMA LINDA, CA 92354 - Phone
- (909) 558-2191
Quick Facts
- NPI
- 1518983113
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile